Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Deccan Fine Chemicals (India) Private Limited is a leading manufacturing company in the fine chemicals industry, specializing in the production of active pharmaceutical ingredients (APIs) and intermediates. The company offers a diverse range of high-quality chemical products for pharmaceuticals, agrochemicals, and specialty chemicals, addressing the specific needs of its clients while ensuring compliance with stringent regulatory standards.
Deccan Fine Chemicals (India) Private Limited, is an unlisted private company incorporated on 24 August, 2006. It is classified as a private limited company and is located in , Telangana. It's authorized share capital is INR 65.00 cr and the total paid-up capital is INR 46.87 cr.
Read more
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Managing Director | Satyanarayana Gokaraju | 00524152 | 18 years |
| Whole-time Director | Venkata Lakshmipathi Raju Kanumuri
Shareholder
|
02000929 | 18 years |
| Whole-time Director | Vivek Vasant Save
Shareholder
|
05191822 | 7 years |
| Director | Takahiro Tokuda | 09544810 | 4 years |
| Whole-time Director | Datla Venkata Satyanarayana Raju
Shareholder
|
01641921 | 2 years |
| Managing Director | Satyanarayana Gokaraju | 00524152 | 18 years |
| Whole-time Director | Venkata Lakshmipathi Raju Kanumuri
Shareholder
|
02000929 | 18 years |
| Whole-time Director | Vivek Vasant Save
Shareholder
|
05191822 | 7 years |
| Director | Takahiro Tokuda | 09544810 | 4 years |
| Whole-time Director | Datla Venkata Satyanarayana Raju
Shareholder
|
01641921 | 2 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | 3,585.4 | 4,192.2 | 6,031.7 | 8,382.7 | 8,101.5 |
| Operating profit | 923.5 | 1,190.1 | 1,565.2 | 2,247.4 | 2,131.5 |
| Net profit | 503.1 | 668.4 | 880.4 | 1,124.0 | 974.0 |
| Gross margin | 41.4 | 43.3 | 41.1 | 40.8 | 41.0 |
| Operating margin | 25.8 | 28.4 | 25.9 | 26.8 | 26.3 |
| Net margin | 13.7 | 15.8 | 14.3 | 13.1 | 11.8 |
| Networth | 1,533.0 | 2,113.4 | 2,906.8 | 3,865.4 | 4,675.9 |
| Borrowings | 2,067.9 | 2,236.5 | 3,428.5 | 4,492.7 | 5,419.1 |
| Assets | 4,533.3 | 5,727.7 | 7,741.4 | 9,959.0 | 11,817.8 |
| Debt to equity | 1.4 | 1.1 | 1.2 | 1.2 | 1.2 |
| Current ratio | 1.5 | 1.2 | 0.9 | 1.1 | 1.0 |
| ROE | 32.8 | 31.6 | 30.3 | 29.1 | 20.8 |
| Days payable | 87.0 | 96.0 | 101.0 | 74.0 | 76.0 |
| WC days | 64.0 | 28.0 | -13.0 | 10.0 | -6.0 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | 46.9 | 46.9 | 46.9 | 46.9 | 46.9 |
| Reserves | 1,486.1 | 2,066.5 | 2,859.9 | 3,818.5 | 4,629.0 |
| Borrowings + | 2,067.9 | 2,236.5 | 3,428.5 | 4,492.7 | 5,419.1 |
| Long term borrowings | 1,499.0 | 1,691.1 | 1,225.2 | 2,240.5 | 2,921.2 |
| Short term borrowings | 568.9 | 545.4 | 2,203.3 | 2,252.2 | 2,497.9 |
| Trade payables + | 503.2 | 623.1 | 980.4 | 1,012.1 | 1,001.7 |
| Days payable | 87.0 | 96.0 | 101.0 | 74.0 | 76.0 |
| Other liabilities + | 932.4 | 1,377.7 | 1,406.1 | 1,600.9 | 1,722.8 |
| Other non-current liabilities | 214.6 | 128.6 | 189.2 | 239.7 | 318.6 |
| Other current liabilities | 214.6 | 626.0 | 236.5 | 349.1 | 402.4 |
| Total liabilities | 4,533.3 | 5,727.7 | 7,741.4 | 9,959.0 | 11,817.8 |
| Fixed Assets + | 2,412.6 | 3,383.4 | 4,228.5 | 5,562.2 | 7,438.9 |
| Tangible assets | 1,757.7 | 2,998.8 | 3,799.6 | 4,742.0 | 6,356.9 |
| CWIP | 654.9 | 384.6 | 428.9 | 820.2 | 1,081.9 |
| Intangible assets | - | - | - | - | - |
| LT loans and advances | - | 14.0 | 8.8 | 7.2 | - |
| Other non-current assets | 202.9 | 216.0 | 299.0 | 549.4 | 600.9 |
| Current assets + | 1,917.8 | 2,114.2 | 3,205.2 | 3,840.1 | 3,778.1 |
| Inventories | 623.7 | 928.3 | 1,559.3 | 2,184.3 | 1,985.3 |
| Trade receivables | 749.6 | 673.5 | 1,006.0 | 922.3 | 1,245.0 |
| Cash and cash equivalents | 407.1 | 367.6 | 498.4 | 463.1 | 269.6 |
| ST loans and advances | 138.1 | - | - | 1.6 | - |
| Other current assets | -0.7 | 144.8 | 141.5 | 268.8 | 278.2 |
| Total assets | 4,533.3 | 5,727.7 | 7,741.4 | 9,959.0 | 11,817.8 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | 3,585.4 | 4,192.2 | 6,031.7 | 8,382.7 | 8,101.5 |
| Sales growth % | 31.81 | 16.92 | 43.88 | 38.98 | -3.35 |
| Expenses + | 3,049.7 | 3,314.8 | 4,965.0 | 7,062.0 | 6,935.5 |
| Cost of goods | 2,099.7 | 2,376.1 | 3,553.2 | 4,965.1 | 4,782.9 |
| Employee cost | 159.2 | 159.2 | 188.5 | 233.9 | 278.5 |
| Other costs | 403.1 | 466.8 | 724.8 | 936.3 | 908.5 |
| Operating profit + | 923.5 | 1,190.1 | 1,565.2 | 2,247.4 | 2,131.5 |
| Operating margin % | 25.8 | 28.4 | 25.9 | 26.8 | 26.3 |
| Other income | 81.0 | 45.5 | 114.6 | 192.5 | 146.0 |
| Interest | 183.2 | 118.6 | 214.0 | 542.7 | 455.7 |
| Depreciation | 204.6 | 194.1 | 284.5 | 384.0 | 509.9 |
| Exceptional items | - | - | - | - | - |
| Profit before tax | 616.7 | 922.9 | 1,181.3 | 1,513.2 | 1,311.9 |
| Tax | 113.6 | 254.5 | 301.0 | 389.2 | 337.9 |
| Profit - disc. ops | - | - | - | - | - |
| Net profit | 503.1 | 668.4 | 880.4 | 1,124.0 | 974.0 |
| Net margin % | 13.7 | 15.8 | 14.3 | 13.1 | 11.8 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | 1.4 | 1.1 | 1.2 | 1.2 | 1.2 |
| Net Debt/Equity | 1.1 | 0.9 | 1.0 | 1.0 | 1.1 |
| Total Debt/Assets | 0.5 | 0.4 | 0.4 | 0.5 | 0.5 |
| Total Assets/Equity | 3.0 | 2.7 | 2.7 | 2.6 | 2.5 |
| Liquidity + | |||||
| Current Ratio | 1.5 | 1.2 | 0.9 | 1.1 | 1.0 |
| Quick Ratio | 1.0 | 0.7 | 0.5 | 0.5 | 0.5 |
| Interest Coverage | 5.0 | 10.0 | 7.3 | 4.1 | 4.7 |
| Performance | |||||
| Gross Margin | 41.4 | 43.3 | 41.1 | 40.8 | 41.0 |
| Operating Margin | 25.8 | 28.4 | 25.9 | 26.8 | 26.3 |
| Net Margin | 13.7 | 15.8 | 14.3 | 13.1 | 11.8 |
| Return + | |||||
| Return on Equity | 32.8 | 31.6 | 30.3 | 29.1 | 20.8 |
| Pre-tax ROCE | 23.6 | 26.9 | 31.9 | 32.2 | 22.2 |
| Return on Assets | 11.1 | 11.7 | 11.4 | 11.3 | 8.2 |
| Pre-tax ROIC | 22.5 | 25.0 | 21.9 | 23.6 | 16.5 |
| Efficiency + | |||||
| Days Payable | 87.0 | 96.0 | 101.0 | 74.0 | 76.0 |
| Days Inventory | 108.0 | 143.0 | 160.0 | 161.0 | 152.0 |
| Days Receivable | 76.0 | 59.0 | 61.0 | 40.0 | 56.0 |
| Fixed Asset Turnover | 1.5 | 1.2 | 1.4 | 1.5 | 1.1 |
| Total Asset Turnover | 0.8 | 0.7 | 0.8 | 0.8 | 0.7 |
| Working Capital | |||||
| Cash Conversion Cycle | 97.0 | 106.0 | 120.0 | 127.0 | 132.0 |
| Working Capital Days | 64.0 | 28.0 | -13.0 | 10.0 | -6.0 |
SBICap Trustee Company Limited
No. of Loans: 6
Total Amount : 26,580.2 cr
IndusInd Bank Limited
No. of Loans: 2
Total Amount : 500.0 cr
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| SURREAL TECHNOLOGIES INDIA PRIVATE LIMITED |
Active
|
1.3 L | 1 | Telangana |
| LONZA INFRASTRUCTURE PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| ESCIENTIA BIOPHARMA PRIVATE LIMITED |
Active
|
1.1 Cr | 1 | Telangana |
| ESCIENTIA ADVANCED SCIENCES PRIVATE LIMITED |
Active
|
21.5 Cr | 1 | Telangana |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| DECCAN ADVANCED SCIENCES PRIVATE LIMITED | Telangana | 2020 | ₹ 967.5 Cr |
| ESCIENTIA ADVANCED SCIENCES PRIVATE LIMITED | Telangana | 2013 | ₹ 21.5 Cr |
| ESCIENTIA BIOPHARMA PRIVATE LIMITED | Telangana | 2008 | ₹ 1.1 Cr |
| Deccan Fine Chemicals USA LLC, USA | United States | - | - |
| Primopus A.G., Switzerland | Switzerland | - | - |
| Escientia Life Sciences LLC, USA | United States | - | - |
Read more
The incorporation date of DECCAN FINE CHEMICALS (INDIA) PRIVATE LIMITED is 24 August, 2006
The authorized share capital of DECCAN FINE CHEMICALS (INDIA) PRIVATE LIMITED is INR ₹ 65.0 Cr.
The paid-up capital of DECCAN FINE CHEMICALS (INDIA) PRIVATE LIMITED is INR ₹ 46.9 Cr.
The registered address of DECCAN FINE CHEMICALS (INDIA) PRIVATE LIMITED is 8-2-293/82/A/74A, ROAD NO.9 JUBILEE HILLS, HYDERABAD, Telangana, India, 500033 - 500033
The CIN number of DECCAN FINE CHEMICALS (INDIA) PRIVATE LIMITED is U24117TG2006PTC050967.